Atlas Trials

A Study on the Treatment Strategy of NVG Secondary to PDR

Clinical trial NCT05156021 · COMPLETED

Trial details

NCT number
NCT05156021
Sponsor
Ruijin Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Neovascular GlaucomaProliferative Diabetic Retinopathy
Start date
2021-12-12
Primary completion
2022-12-31
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.